Close X
Monday, November 11, 2024
ADVT 
Health

Personalised vaccines for cancer a step closer

Darpan News Desk IANS, 30 Nov, 2014 01:49 PM
    Researchers have developed a strategy to create personalised vaccines that spur the immune system to attack harmful tumours.
     
    Scientists at the Washington University in the US are already evaluating personalised cancer vaccines in patients with metastatic melanoma in clinical trials.
     
    The researchers are also working to use the vaccines against breast, brain, lung, head and neck cancers.
     
    Additional trials are anticipated in the next couple of years.
     
    In the new study, the scientists tested vaccines in computer simulations, cell cultures and animal models.
     
    The results showed that the vaccines could enable the immune system to destroy or drive into remission a significant number of tumours.
     
    The vaccines cured nearly 90 percent of mice with an advanced form of muscle cancer.
     
    "This is proof that personalised cancer vaccines can be very powerful and need to be applied to human cancers now," said senior author Robert Schreiber.
     
    Creating a personalised vaccine begins with samples of DNA from a patient's tumour and normal tissue.
     
    Researchers sequence the DNA to identify mutant cancer genes that make versions of proteins found only in the tumour cells. Then they analyse those proteins to determine which are most likely to be recognised and attacked by immune T cells. Portions of these proteins are incorporated into a vaccine to be given to a patient
     
    The technique was inspired by a therapy scientists call checkpoint blockade. This immune-based cancer treatment, which has been successful against advanced lung and skin cancers in clinical trials, takes advantage of immune T cells that are present in many tumours but are shut off by cancer cells.
     
    The study appeared in the journal Nature.

    MORE Health ARTICLES

    Artificial retina could help restore vision of elderly

    Artificial retina could help restore vision of elderly
    A team of researchers has created a wireless and light-sensitive, flexible film that could potentially substitute a damaged retina....

    Artificial retina could help restore vision of elderly

    Flawed gene may curb heart attack risk by half

    Flawed gene may curb heart attack risk by half
    Rare mutations that shut down a single gene called NPC1L1 are linked to lower cholesterol levels and a 50 percent reduction in the risk of heart attack, says an Indian-origin cardiologist....

    Flawed gene may curb heart attack risk by half

    Vitamin B doesn't stem memory loss

    Vitamin B doesn't stem memory loss
    A day before Indian Prime Minister Narendra Modi arrives in Brisbane for the G20 summit, Australia is waiting anxiously for the Indian Prime Minister's overdue visit to commence....

    Vitamin B doesn't stem memory loss

    Personalized Genetic Test Could Predict Prostate Cancer Recurrence

    Personalized Genetic Test Could Predict Prostate Cancer Recurrence
    TORONTO — Canadian researchers have developed a genetic test to identify which men are at highest risk for recurrence of prostate cancer following localized treatment with surgery or radiation therapy.

    Personalized Genetic Test Could Predict Prostate Cancer Recurrence

    Oral cancer virus spreads via oral, genital route

    Oral cancer virus spreads via oral, genital route
    Transmission of human papillomavirus (HPV) occurs via oral-oral and oral-genital routes, says new research....

    Oral cancer virus spreads via oral, genital route

    A virus that could affect brain's activities

    A virus that could affect brain's activities
    People with algae virus in their throats had more difficulty completing a mental exercise than healthy people, and more research is needed to understand why...

    A virus that could affect brain's activities